The 6th Glioblastoma Drug Development Summit covers topics such as:
- Reflecting on Progress: Positive Clinical Readouts, Reverse Insights & Actionable Lessons for Glioblastoma Drug Developers
- Surpassing the Blood Brain Barrier to Unlock the Potential of New Therapeutic Agents
- Optimizing Clinical Trial Design for GBM – Uncovering Past Lessons to Redefine Future Trial Outcomes
- Optimizing Predictive Validity for Risk Mitigation in GBM Drug Development Across All Phases
- Current Landscape of GBM Precision Therapeutics
The 6th Glioblastoma Drug Development Summit might be held in Boston, United States in Mar 2025.